SCHEMBL23567451

SCHEMBL23567451

Cc1ccoc1-c1ccccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.43
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
NOTUM Q6P988 1/20 0.39
MBNL1 Q9NR56 1/20 0.39
PTPRC P08575 1/20 0.38
NMUR2 Q9GZQ4 1/20 0.37
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
MEN1 O00255 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
KMT2A Q03164 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23567051 0.81 NPC1 (0.43) ACHERAB9ANPC1GAASMN1; SMN2
SCHEMBL13393531 0.77 NQO1 (0.37) MEN1KMT2ANQO1PORALDH1A1
SCHEMBL23567431 0.76 HSD11B1 (0.46) ADRA1DADRA1AADRA1BNOTUMALDH1A1
SCHEMBL23567062 0.73 ADRA1D (0.50) RAB9ANPC1GAASMN1; SMN2ADRA1D
SCHEMBL23566250 0.73 ALDH1A1 (0.47) RAB9ANPC1GAASMN1; SMN2ADRA1D
SCHEMBL13380091 0.72 LMNA (0.46) SMN1; SMN2MEN1KMT2ANQO1POR
SCHEMBL1443578 0.72 NQO1 (0.41) ADRA1DADRA1AADRA1BPTPRCNQO1
SCHEMBL10166445 0.70 CHRM2 (0.38) ACHERAB9ANPC1SMN1; SMN2ADRA1D
SCHEMBL2968620 0.69 ADRA1D (0.39) ADRA1DADRA1AADRA1BPTPRCNQO1
SCHEMBL9955370 0.69 NOTUM (0.44) ACHERAB9ANPC1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210186927-A1 COMBINATION PRODUCT FOR THE INDUCTION AND/OR MAINTENANCE OF GENERAL ANESTHESIA TERRAN BIOSCIENCES, INC. 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210186927-A1 COMBINATION PRODUCT FOR THE INDUCTION AND/OR MAINTENANCE OF GENERAL ANESTHESIA OPRK1, OPRD1, GABRD ACHE 438/4885RAB9A 3441/4885NPC1 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.